PCID2 and hepatocellular carcinoma: To address them, ongoing studies in our laboratory, including lentiviral gain- and loss-of-function models, as well as transcriptomic and proteomic analyses, are expected to provide causal evidence for the PCID2-dependent effects of β-PGG and further clarify its biological function role in HCC.